Back to Trials
NCT06417177EARLY_PHASE1RecruitingAccepts Healthy Volunteers

Impact of Early Aging and Menopause on the Vascular Responses to Hypoxia

University of Missouri-Columbia

Start Date

6/3/2024

Completion Date

7/1/2026

Summary

The purpose of this study is to examine hypoxic vasodilation and the role of beta-adrenergic receptors in younger premenopausal, perimenopausal, and older postmenopausal women.

Eligibility Criteria

Age Range: 18 years to 70 years

Inclusion Criteria: * Female assigned at birth * Pre, peri- or post-menopausal * Healthy weight (BMI ≥18 and ≤30 kg/m2) Exclusion Criteria: * Male (assigned at birth) * Pregnancy, breastfeeding * Use of hormone replacement therapies * Hysterectomy * Body mass index \>30 kg/m2 * Diagnosed sleep apnea * Current smoking/Nicotine/Drug use * Nerve/neurologic disease * Cardiovascular, hepatic, renal, respiratory disease * Blood pressure ≥140/90 mmHg * Diabetes, Polycystic ovarian syndrome * Communication barriers * Prescription medications * Malignant cancer

Interventions

DRUG

Placebo

DRUG

Propranolol

DRUG

Gemtesa

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

AgingMenopauseHypoxiaVasodilation

Locations

University of Missouri-Columbia

Columbia, Missouri 65211

United States